A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice
Condition: Non-Hodgkin Lymphoma, B-cell Intervention: Drug: " novel " MAB (alone or in combination) Sponsors: Fondazione Italiana Linfomi - ETS; Roche Pharma AG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials